Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 07 2021
Historique:
pubmed: 29 5 2021
medline: 11 1 2022
entrez: 28 5 2021
Statut: ppublish

Résumé

Repeat expansion of CGG in LRP12 has been identified as the causative variation of oculopharyngodistal myopathy (OPDM). However, to our knowledge, the clinicopathologic features of OPDM with CGG repeat expansion in LRP12 (hereafter referred to as OPDM_LRP12) remain unknown. To identify and characterize the clinicopathologic features of patients with OPDM_LRP12. This case series included 208 patients with a clinical or clinicopathologic diagnosis of oculopharyngeal muscular dystrophy (OPDM) from January 1, 1978, to December 31, 2020. Patients with GCN repeat expansions in PABPN1 were excluded from the study. Repeat expansions of CGG in LRP12 were screened by repeat primed polymerase chain reaction and/or Southern blot. Clinical information, muscle imaging data obtained by either computed tomography or magnetic resonance imaging, and muscle pathologic characteristics. Sixty-five Japanese patients with OPDM (40 men [62%]; mean [SD] age at onset, 41.0 [10.1] years) from 59 families with CGG repeat expansions in LRP12 were identified. This represents the most common OPDM subtype among all patients in Japan with genetically diagnosed OPDM. The expansions ranged from 85 to 289 repeats. A negative correlation was observed between the repeat size and the age at onset (r2 = 0.188, P = .001). The most common initial symptoms were ptosis and muscle weakness, present in 24 patients (37%). Limb muscle weakness was predominantly distal in 53 of 64 patients (83%), but 2 of 64 patients (3%) had predominantly proximal muscle weakness. Ptosis was observed in 62 of 64 patients (97%), and dysphagia or dysarthria was observed in 63 of 64 patients (98%). A total of 21 of 64 patients (33%) had asymmetric muscle weakness. Aspiration pneumonia was seen in 11 of 64 patients (17%), and 5 of 64 patients (8%) required mechanical ventilation. Seven of 64 patients (11%) developed cardiac abnormalities, and 5 of 64 patients (8%) developed neurologic abnormalities. Asymmetric muscle involvement was detected on computed tomography scans in 6 of 27 patients (22%) and on magnetic resonance imaging scans in 4 of 15 patients (27%), with the soleus and the medial head of the gastrocnemius being the worst affected. All 42 muscle biopsy samples showed rimmed vacuoles. Intranuclear tubulofilamentous inclusions were observed in only 1 of 5 patients. This study suggests that OPDM_LRP12 is the most frequent OPDM subtype in Japan and is characterized by oculopharyngeal weakness, distal myopathy that especially affects the soleus and gastrocnemius muscles, and rimmed vacuoles in muscle biopsy.

Identifiants

pubmed: 34047774
pii: 2780424
doi: 10.1001/jamaneurol.2021.1509
pmc: PMC8164150
doi:

Substances chimiques

LRP12 protein, human 0
Low Density Lipoprotein Receptor-Related Protein-1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-863

Auteurs

Theerawat Kumutpongpanich (T)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Masashi Ogasawara (M)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Ayami Ozaki (A)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Hiroyuki Ishiura (H)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Shoji Tsuji (S)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Narihiro Minami (N)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Shinichiro Hayashi (S)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Satoru Noguchi (S)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Aritoshi Iida (A)

Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Madoka Mori-Yoshimura (M)

Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Yasushi Oya (Y)

Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Kenjiro Ono (K)

Division of Neurology, Department of Internal Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.

Toshio Shimizu (T)

Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.

Akihiro Kawata (A)

Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.

Shun Shimohama (S)

Department of Neurology, Sapporo Medical University, Sapporo, Japan.

Keiko Toyooka (K)

Department of Neurology, Osaka Toneyama Medical Center, Osaka, Japan.

Kaoru Endo (K)

Department of Neurology, Tohoku University School of Medicine, Miyagi, Japan.

Shuta Toru (S)

Department of Neurology, Nitobe Memorial Nakano General Hospital, Tokyo, Japan.

Oga Sasaki (O)

Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan.

Kenji Isahaya (K)

Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan.

Masanori P Takahashi (MP)

Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Kazuo Iwasa (K)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Jun-Ichi Kira (JI)

Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Tatsuya Yamamoto (T)

Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Michi Kawamoto (M)

Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.

Tadanori Hamano (T)

Second Department of Internal Medicine, Division of Neurology, Department of Aging and Dementia, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Kazuma Sugie (K)

Department of Neurology, Nara Medical University, Nara, Japan.

Nobuyuki Eura (N)

Department of Neurology, Nara Medical University, Nara, Japan.

Tomo Shiota (T)

Department of Neurology, Nara Medical University, Nara, Japan.

Mizuho Koide (M)

Department of Neurology, Chiba-East National Hospital, Chiba, Japan.

Kanako Sekiya (K)

Department of Neurology, Niigata City General Hospital, Niigata, Japan.

Hideaki Kishi (H)

Department of Neurology, Asahikawa Medical Center, Asahikawa, Japan.

Takuto Hideyama (T)

Department of Neurology, Tokyo Medical University, Tokyo, Japan.

Shigeru Kawai (S)

Department of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.

Satoshi Yanagimoto (S)

Department of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.

Hiroyasu Sato (H)

Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Hajime Arahata (H)

Department of Neurology, National Hospital Organization Omuta National Hospital, Omuta, Japan.

Shigeo Murayama (S)

Department of Neurology and Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital, Institute of Gerontology, Tokyo, Japan.

Kayoko Saito (K)

Institute of Medical Genetics, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.

Hideo Hara (H)

Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.

Takashi Kanda (T)

Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Hiroshi Yaguchi (H)

Department of Neurology, The Jikei University Kashiwa Hospital, Kashiwa, Japan.

Noboru Imai (N)

Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.

Yuichi Kawagashira (Y)

Department of Neurology, Tsushima City Hospital, Aichi, Japan.

Mitsuru Sanada (M)

Department of Neurology, Kanazawa Medical University Hospital, Ishikawa, Japan.

Kazuki Obara (K)

Department of Neurology, Anjo Kosei Hospital, Aichi, Japan.

Misako Kaido (M)

Department of Neurology, Sakai City Medical Center, Osaka, Japan.

Minori Furuta (M)

Department of Neurology, Gunma University, Maebashi, Japan.

Takashi Kurashige (T)

Department of Neurology, National Hospital Organization Kure Medical Center, Chugoku Cancer Center, Kure, Japan.

Wataru Hara (W)

Department of Neurology, Saitama Medical Center, Saitama, Japan.

Daisuke Kuzume (D)

Department of Neurology, Chikamori Hospital, Kochi, Japan.

Mamoru Yamamoto (M)

Department of Neurology, Toyama University, Toyama, Japan.

Jun Tsugawa (J)

Department of Neurology, Fukuoka University, Fukuoka, Japan.

Hitaru Kishida (H)

Department of Neurology, Yokohama City University Medical Center, Yokohama, Japan.

Naoki Ishizuka (N)

Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan.

Kohei Morimoto (K)

Department of Neurology, Kobe University, Kobe, Japan.

Yukio Tsuji (Y)

Department of Neurology, Kobe University, Kobe, Japan.

Atsuko Tsuneyama (A)

Department of Neurology, Narita Red Cross Hospital, Chiba, Japan.

Atsuhiro Matsuno (A)

Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.

Ryo Sasaki (R)

Department of Neurology, Okayama University, Okayama, Japan.

Daigo Tamakoshi (D)

Department of Neurology, Chukyo Hospital, Nagoya, Japan.

Erika Abe (E)

Department of Neurology, National Hospital Organization Akita Hospital, Akita, Japan.

Shinichiro Yamada (S)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Akiyuki Uzawa (A)

Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH